During the past decade, Calvary Health Care Bethlehem conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Calvary Health Care Bethlehem" #1 sponsor was "Wave Life Sciences Ltd." with 4 trials, followed by "Knopp Biosciences" with 2 trials sponsored, "Stealth BioTherapeutics Inc." with 2 trials sponsored, "Macquarie University, Australia" with 1 trials sponsored and "Neuroscience Trials Australia" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Calvary Health Care Bethlehem" #1 collaborator was "Calvary Health Care Bethlehem" with 2 trials as a collaborator, "Macquarie University, Australia" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Deakin University" with 1 trials as a collaborator and "FightMND" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Calvary Health Care Bethlehem" are "Amyotrophic Lateral Sclerosis" (5 trials), "Huntington Disease" (3 trials), "Huntington's Disease" (2 trials), "Mitochondrial Complex I Deficiency" (1 trials) and "Mitochondrial DNA Deletion" (1 trials). Many other conditions were trialed in "Calvary Health Care Bethlehem" in a lesser frequency.

Most popular intervention types in "Calvary Health Care Bethlehem" are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Dexpramipexole" (2 trials), "WVE-120101" (2 trials), "WVE-120102" (2 trials) and "Dolutegravir, Abacavir and Lamivudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Calvary Health Care Bethlehem" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Calvary Health Care Bethlehem". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Calvary Health Care Bethlehem, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Calvary Health Care Bethlehem, 5 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".